Massey Cancer Center, Virginia Commonwealth University
Medical Oncology
Dr. Leslie Randall Gynecologic Oncologist at VCU Massey Cancer Center Professor and Director, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, VCU School of Medicine Leslie M. Randall, M.D., MAS, FACS, is a gynecologic oncologist and the Diane Harris Wright Professor and Director of the Division of Gynecologic Oncology at VCU Massey Cancer Center, as well as Professor in the Department of Obstetrics and Gynecology at the VCU School of Medicine. She joined VCU in January 2020 from the University of California Irvine Medical Center, where she was an Associate Professor of Obstetrics and Gynecology and Director of Medical Education and the ACGME-accredited Gynecologic Oncology Fellowship. An accomplished clinician and skilled surgeon, Dr. Randall has expertise in minimally invasive, robotic and radical cytoreductive procedures, including HIPEC (hyperthermic intraperitoneal chemotherapy). She has extensive experience with complex and novel chemotherapy regimens and clinical trials. Her practice also encompasses the care of women with genetic predisposition to gynecologic cancer and those seeking fertility-sparing options. Dr. Randall is very active in developing and leading clinical trials and has served as the principal investigator of many trials on local, national and international levels. She serves on the NRG Oncology Developmental Therapeutics and Ovarian Cancer Committees, and the Gynecologic Oncology Group (GOG) Foundation Board of Directors. She currently serves as Lead Cervical Cancer Clinical Trials Advisor for the GOG Partners Leadership Committee.

Moderator of 1 Session

Session Type
Industry Symposia
Date
09/30/2022
Session Time
12:25 PM - 01:55 PM
Room
Hall 501
Session Description

It takes a village: Interdisciplinary management of patients with advanced cervical cancer - Industry Symposium by Seagen Inc. & Genmab

Session Description:

•Increased knowledge regarding:

*Clinical data for the FDA Approved and newer therapies in advanced and recurrent/metastatic Cervical Cancer

*The current investigational agents and regimens under evaluation for early, advanced, and recurrent/metastatic Cervical Cancer

•Greater competence related to:

*Selecting therapies and treatments for women with advanced and recurrent/metastatic Cervical Cancer

*Understanding on appropriate Biomarkers

*Understanding antibody drug conjugate technology (ADCs)

*Reducing treatment related issues and proactively managing side effects.

•Greater confidence in their ability to:

*Counsel patients with Cervical cancer on available therapies

*Obtaining the patient perspective

*Discuss options with your pharmacist.

Presenter of 6 Presentations

Panel Discussion Regarding Patient Journey and Interdisciplinary Team Interaction

• Decentralized Clinical Trials: How it Can Work

Session Type
Pre-Meeting Workshops
Date
09/28/2022
Session Time
10:30 AM - 05:00 PM
Room
Hall 405
Session Icon
On-Demand
Lecture Time
11:42 AM - 11:52 AM
Onsite or Pre-Recorded
Onsite

Recurrent Metistatic Cervical Cancer – What Your Treatment Options Mean to Your Team

Session Type
Industry Symposia
Date
09/30/2022
Session Time
12:25 PM - 01:55 PM
Room
Hall 501
Lecture Time
12:45 PM - 12:55 PM

Distillation & Q&A

Session Type
Plenary Session
Date
09/29/2022
Session Time
08:00 AM - 10:30 AM
Room
Hall 501
Session Icon
Live
Lecture Time
09:27 AM - 09:34 AM
Onsite or Pre-Recorded
Onsite